SEC Form 4 · accession 0001193125-26-357121
GLOBUS MEDICAL INC · GMED
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen T Zarrilli
Director
Period of report
Aug 18, 2026
Accepted (ET)
Aug 19, 2026 · 5:07 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001237831
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Aug 18, 2026 | M | 25,000 | $53.27 | A | 25,000 | D | |
| Class A Common StockF1 | Aug 18, 2026 | S | 25,000 | $87.0386 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)F2 | $53.27 | Aug 18, 2026 | M | 25,000 | D | — | Jan 22, 2030 | Class A Common Stock | 25,000 | 0 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.92 to $87.16, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
- F2These options were granted on January 22, 2020 and are fully vested.